1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
August 21, 1997
CARACO PHARMACEUTICAL LABORATORIES, LTD.
------------------------------------------------
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER
Michigan 0-24676 38-25-5723
---------------------------- ------------------- -------------------
(STATE OR OTHER JURISDICTION COMMISSION FILE NO. IRS EMPLOYER ID NO.
OF INCORPORATION)
1150 Elijah McCoy Drive, Detroit, MI 48202
-------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
REGISTRANT'S TELEPHONE NO.: (313) 871-8400
The Exhibit Index is located on page 3.
The total number of pages is 5.
2
ITEM 5. OTHER EVENTS.
On August 21, 1997 Caraco Pharmaceutical Laboratories Ltd. announced
the finalization of agreements with Sun Pharma of India and the Economic
Development Corporation of Detroit. Additional details are set forth on the
attached public announcement (EXHIBIT A).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
/s/ Allan J. Hammer
-----------------------------------------
Allan J. Hammer
Chief Financial Officer
(A duly authorized signatory
of the Company)
DATED: August 21, 1997
3
EXHIBIT INDEX
Exhibit Table
Number Exhibit Page
- ----------------------------------------------------------------------------
99 EXHIBIT A - Company's Press Release 4
dated August 21, 1997